Cervical screening is changing – here's what the new 5-year test means for you
Smear tests are nobody's favourite, but they're a vital part of healthcare. Now, the way you're tested for HPV is changing.
From July, invitations for cervical screening will be sent out every five years instead of every three for women aged 25-49 in England. Those with positive tests will still be required to have more regular check ups to make sure the HPV is clearing and no cell changes have occurred.
HPV (human papillomavirus) causes almost all cervical cancers. However, most cases of HPV do not develop into the disease and are removed naturally by the body. Recent updates to HPV testing makes it more accurate, allowing less frequent testing to take place, according to the NHS.
It says the changes are part of a 'more personalised' approach to testing that's in line with 'major clinical research'. It's also rolling out bookings via the NHS app, though letters will still be in place for those need them.
This change to screenings has already made in Scotland and Wales, and follows the cervical screening recommendations from the UK National Screening Committee (UK NSC), an independent body of experts who review screening evidence and advise the four UK governments.
While it may sound scary to hear you'll be tested less frequently, cancer charities are on board with the move. Michelle Mitchell, chief executive of Cancer Research UK, says: 'We welcome this change to cervical screening in England, which is the result of years of vital research to make screening more effective and has shown it is safe to extend the time between tests. Screening, alongside the roll out of the HPV vaccine, which Cancer Research UK scientists helped develop, have seen cervical cancer rates drop by around a quarter since the early 1990s, and we look forward to even more progress.'
Athena Lamnisos, chief executive officer at The Eve Appeal, added: 'Every single case of cancer that can be prevented, should be, and this new guidance is good news for those at low risk because they will no longer need to go for cervical screening as often. Everyone should feel informed and supported when they are invited to go to their cervical screening appointment and understand these interval changes and why they will keep them protected.'
Cervical screening is to test for symptomless cases of HPV. If you notice any changes that are unusual for you, or experience symptoms including unusual vaginal bleeding, changes to discharge, painful sex or pain in your abdomen, lower back or pelvic area, don't wait for your smear – talk to your GP right away.
You Might Also Like
13 Buys To Help You Feel Great From £5
16 Speedo Swimsuits that Won't Flash Your Bum When Getting Swim-fit
11 Best Gym Trainers for Different Types of Workouts
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
an hour ago
- Medscape
Sudden Cardiac Arrest Is Highly Preventable: Here's How
This transcript has been edited for clarity. This is Dr JoAnn Manson, professor of medicine at Harvard Medical School and Brigham and Women's Hospital. I'd like to talk with you about a recent report in the Canadian Journal of Cardiology that addressed the modifiable risk factors for sudden cardiac arrest, the extent to which this outcome is preventable, and the percentage of cases that could be averted by changes in modifiable risk factors. There's been surprisingly little research on this subject. Most of the research on sudden cardiac arrest has looked at genetic factors and clinical risk factors that are managed with pharmacologic agents, such as hypertension, high cholesterol, and diabetes, and proximate risk factors like what the patient was doing shortly before the sudden cardiac arrest. However, there's been very little research on the role of behavioral and lifestyle factors in long-term studies. It's important to have this research because we know that sudden cardiac arrest is highly fatal in about 90% of cases. In the US alone, there are more than 200,000 cases per year, and more than double that if we include total cardiac arrest inside and outside of the hospital. In the present study, researchers leveraged the large-scale UK Biobank, which included more than 500,000 participants whose mean age was 56 years and about 50% of whom were women. Over a follow-up of 14 years, there were about 3100 cases of incident sudden cardiac arrest. The researchers looked at about 125 risk factors and linked 56 of those factors to the risk for sudden cardiac arrest. These included lifestyle, behavioral, adiposity, psychosocial, and environmental factors. What they found was that the American Heart Association Life's Essential 8 factors were generally strongly related to risk for sudden cardiac arrest. For example, sedentary lifestyle, higher adiposity, higher waist circumference, short sleep duration (less than 7 hours per night), and tobacco use were associated with an increased risk. Other factors that were also linked to sudden cardiac arrest risk included psychosocial factors (eg, depressive symptoms, low mood, social isolation), dietary factors (eg, low fruit and vegetable intake), and air pollution. The researchers used Mendelian randomization to evaluate the likelihood of a causal relationship. In these analyses, about nine factors were determined to be causally related. These factors included adiposity factors, low fruit intake, low educational level, and some of the mood-related factors. Overall, they estimated that between 40% and 63% of sudden cardiac arrest cases could be preventable by reducing or even fully eliminating these risk factors. These findings underscore the importance of primary prevention, not only to nonfatal or total coronary heart disease and cardiovascular events, but also to sudden cardiac arrest. These results suggest that more could be done in terms of informing our patients about these risk factors in order to lower their risk — both informing them in the clinic and through community-based and public health campaigns.
Medscape
an hour ago
- Medscape
Harm Reduction in Alcohol Use Disorder: Lessons From Sex Ed
This transcript has been edited for clarity. Matthew F. Watto, MD: Welcome back to The Curbsiders . I'm Dr Matthew Frank Watto, here with my great friend and America's primary care physician, Dr Paul Nelson Williams. We had an awesome episode with Dr Stephen Holt and our addiction medicine crew, where we had a higher-level focus on medications for alcohol use disorder (AUD), mainly in the outpatient setting. Paul, I think it's important to start off by saying that when we were young people coming up in this field, abstinence was pretty much the only approach in the treatment of AUD. The attitude was that if your patient was unable to reach absolute abstinence, you were a failure. We were also probably calling it "alcoholism" at the time. But now, I think we're starting to take a more realistic, patient-centered, and evidence-based approach by recognizing that abstinence is not realistic for everybody. Instead, just a reduction in alcohol use can improve outcomes, including mortality. You really have to meet the patient where they are in the process. And yes — for many patients, achieving complete abstinence would be most optimal for their overall health, but it may not be in the cards for them, and a reduction in use is worth shooting for. Anything to say about that, Paul? Paul N. Williams, MD: It's all true. I think keeping things patient-centered is always important. We also need to recognize that even if the patient's goal is abstinence, it's really hard. These medications are effective but they're far from perfect. Accept that there may be returns to use and that you may not be able to achieve complete abstinence; be okay with that outcome and support the patient throughout the process. It's critical to avoid viewing it as a treatment failure, regardless of what your patient's goals might be. Watto: We have three FDA-approved medications: Naltrexone (oral or intramuscular), disulfiram, and acamprosate. Paul, I was not familiar with targeted therapy. I thought you had to take these medications every day or once a month. Teach me something, Paul. Williams: With AUD, there are often triggers of alcohol use, and often patients can anticipate what these triggers might be. On the episode we talked about Thanksgiving dinner — where we know an uncle's going to get us angry — or the anniversary of a loved one's death or being in a social situation. There are times when someone will know and recognize that they're going to be more likely to drink alcohol. So rather than being on chronic medication, patients can take medications in advance of whatever this occasion might be to help reduce their potential for use. That can be done with naltrexone — the Sinclair Method — and it sounds like the data are especially good for nalmefene, but it's a European medication that is not approved in the United States. Dr Holt and our colleague, Carolyn Chan, also mentioned doing this with disulfiram as well. This method of taking medication in anticipation of a known trigger — maybe a day or two before — can help patients be less likely to drink alcohol during that time, and can help them avoid all the burdens and hassles that come with being on a chronic medication. It's a neat technique that is not used as commonly as it could be, at least in my experience. Watto: It sounded like Dr Holt advises patients to start the medication a couple days before the known trigger and to continue using the medication until they feel like things are settled again. But Paul, Dr Holt loves disulfiram — I was shocked! I did not know this about him, and I thought no one was using disulfiram anymore. Have you prescribed it, and did you know that it was still "in vogue"? Williams: I have prescribed it, but I don't know if it's "in vogue." It's got a bad reputation and it's not necessarily my first line, but Dr Holt has a lot of enthusiasm for it and he makes a really interesting point. He brought up the fact that the studies that looked at disulfiram were randomized, double-blinded control trials. However, if you're a participant who believes that what you're taking (placebo or not) might make you deathly ill when you drink alcohol, that potential of severe illness will inevitably change patient behavior, regardless of what treatment arm they fall into. That kind of defeats the purpose of studying the efficacy of disulfiram in comparison to placebo. But when you actually look at the results of open-label trials — where patients knew what treatment arm they were randomized into and participants receiving the placebo knew there wasn't a real threat of severe illness — there's good evidence for disulfiram's efficacy in an observed setting. Dr Holt had a lot of personal success with disulfiram, so he was a big advocate for it. Our conversation certainly made me more inclined to prescribe it than I had been prior to the episode, but it's probably still not my first choice. Watto: I thought that was a really smart point about how, typically, randomized, blinded trials are our gold standard, but in this case the placebo becomes very strong in a blinded setting when the patient is not sure whether their treatment will cause them to get horribly ill if they drink. The standard dose of disulfiram is 250 mg. If patients don't become sick after drinking at that dose, Dr Holt said he would up the dose to 500 mg. That usually isn't common, but some patients just don't have that typical response at the standard dose and must be metabolizing alcohol some other way. However, most patients need to be really careful. Patients should avoid all alcohol-containing products, including mouthwash, vanilla extract, and many types of aftershave. The contraindications for disulfiram include: Pregnancy Cognitive impairment, as patients may not remember if they took their medications or not Severe cardiovascular disease, as a reaction can cause ischemia Advanced liver disease (eg, cirrhosis with Child-Pugh class B or C) Dr Holt would still use disulfiram for patients with mild cirrhosis who are considered Child-Pugh class A but recommends following the liver closely. I looked disulfiram up on LiverTox and there is some concern about acute medication-induced hepatitis that could be really serious. So, if a patient already has a sick liver at baseline, you probably don't want to give them this medication. Williams: Beyond the fact that I feel like this medication sometimes feels a little bit moralistic or kind of punitive for people who are drinking, as though it's just a sort of built-in punishment, my larger concern with prescribing disulfiram is the potential for hepatotoxicity. However, that may have been overstated in my brain. Watto: If I had a patient without contraindications, I would at least have a conversation to see if it's the right person, because it does take drinking off the table. Even if they're having cravings, they know they'll get violently ill if they drink and they don't want to end up in an ER for IV fluids because they're vomiting. I think it works, but it requires a little bit of a tricky conversation. But I do think this episode made me reconsider disulfiram as an agent to prescribe. Williams: It goes back to your original point of shared decision-making: We need to make sure we're making informed decisions together and matching treatments with patients' goals. If a patient is interested in disulfiram after a detailed conversation, I would not try to talk them out of it. I'm more inclined to reach for it now after speaking with Dr Holt. Watto: So, Paul, what off-label medications might listeners consider for AUD treatment? Williams: There's a bazillion, and there have been lots of small studies looking at different options and combinations. If you're unable to use the FDA-approved medications, topiramate is the one medication Dr Holt would reach for. It's even highlighted in the Veterans Affairs/Department of Defense guidelines. It can be a tricky medication because it has to be titrated slowly; we're talking about increments of 25 mg. As such, you have to have a patient who can follow directions, is committed to taking a medication, and is fairly well organized, which is not always the case when someone has an underlying AUD. There's also a lot of intolerable side effects for a lot of folks; patients might experience somnolence and paresthesias, so you have to be a little bit cautious with those. However, topiramate does have evidence to support its use. We talk a good bit about gabapentin as well, Matt. It's something that we've all prescribed for a million different reasons. Dr Holt is a fan of it, specifically for alcohol withdrawal, but also there is some evidence for its use with AUD. It seems helpful, especially in combination with, say, naltrexone. I'm more inclined to reach for that. We touched briefly on baclofen, and I've known people who have been enthusiastic about it as an option. There is evidence to support its use, but it's not one we talked too much about this episode. Watto: We also talked a little bit about combination therapy. There's not really strong evidence for it. I know you mentioned that sometimes you might use naltrexone and gabapentin together, but the evidence overall for something like naltrexone and acamprosate didn't seem to pan out. Williams: It's not well supported — correct.
Health Line
an hour ago
- Health Line
Choosing a Medicare Advantage Plan That's Right for You
There are many factors to consider when choosing a Medicare Advantage (Part C) plan, including costs, in-network providers, and coverage for medical services and prescription medications. If you're shopping for a Medicare Advantage (Part C) plan this year, you may wonder what the best plan is for you. It depends on your personal situation, medical needs, how much you can afford, and other factors. Tools are available to help you find Medicare Advantage plans in your area that can meet all your healthcare needs. Glossary of common Medicare terms Out-of-pocket cost: This is the amount you pay for care when Medicare doesn't pay the full cost or offer coverage. It includes premiums, deductibles, coinsurance, and copayments. Premium: This is the monthly amount you pay for Medicare coverage. Deductible: This is the annual amount you must spend out of pocket before Medicare begins to cover services and treatments. Coinsurance: This is the percentage of treatment costs you're responsible for paying out of pocket. With Medicare Part B, you typically pay 20%. Copayment: This is a fixed dollar amount you pay when receiving certain treatments or services. With Medicare, this often applies to prescription medications. Factors to consider when choosing a Medicare Advantage plan With all the changes being made to the Medicare plans on the market, it can be hard to narrow down the best plan for you. Here are a few things to look for in a Medicare Advantage plan: costs that fit your budget and needs a list of in-network providers that includes any doctor(s) you would like to keep coverage for services and medications you know you'll need Centers for Medicare & Medicaid Services (CMS) star rating Research CMS star ratings The CMS has implemented a 5-star rating system to measure the quality of health and drug services provided by Medicare Advantage and Medicare Part D (prescription drug) plans. Every year, the CMS releases these star ratings and additional data to the public. The CMS ratings can be a great place to start when shopping around for the best Medicare Advantage plan in your state. Consider researching these plans for more information on what coverage is included and how much it costs. To see all available Medicare Part C and D 2025 star ratings, visit and download the 2025 Medicare Star Ratings Data Table. Consider your coverage priorities All Medicare Advantage plans cover what Original Medicare covers — this includes hospital coverage (Part A) and medical coverage (Part B). When you choose a Medicare Advantage plan, you first want to consider what type of coverage you need in addition to the coverage above. Most Medicare Advantage plans offer one, if not all, of these additional types of coverage: prescription drug coverage dental coverage, including yearly exams and procedures vision coverage, including yearly exams and vision devices hearing coverage, including exams and hearing devices fitness memberships medical transportation additional healthcare perks Finding the best Medicare Advantage plan means making a checklist of the services you want to receive coverage for. You can then take your coverage checklist to Medicare's find a plan tool and compare plans that cover what you need. If you find a plan that looks good for you, don't be afraid to call the company to ask if they offer any additional coverage or perks. Determine your budget and potential healthcare costs One of the most important things to consider when choosing the best Medicare Advantage plan is how much it will cost you. The find a plan tool lists the following cost information with the plans: monthly premium Part B premium in-network yearly deductible drug deductible in- and out-of-network out-of-pocket max copays and coinsurance To get a starting estimate of your yearly costs, consider the premium, deductible, and out-of-pocket max. Any deductible listed is the amount you'll owe out of pocket before your insurance begins to pay out. Any out-of-pocket max listed is the maximum amount you will pay for the services throughout the year. When estimating your plan costs, consider these costs plus how often you will need to refill prescription drugs or make office visits. If you require specialist or out-of-network visits, include those potential costs in your estimate as well. Remember that your amount may be lower if you receive financial assistance from the state. Review other benefits you may already have If you already receive other types of healthcare benefits, this may factor into what kind of Medicare Advantage plan you'll need. For example, if you already receive Original Medicare and have opted to add Part D or Medigap, many of your needs may already be covered. However, you can always do a coverage comparison to determine whether a Medicare Advantage plan would work better or be more cost-effective for you. What Medicare Advantage plans are available? When beginning your search for a Medicare Advantage (Part C) plan, it's important to know the differences between each type of plan. You'll probably see some or all of the following types of plans when reviewing your options: Health Maintenance Organization (HMO) plans: HMO plans are primarily focused on in-network healthcare services. Preferred Provider Organization (PPO) plans: PPO plans charge different rates depending on whether the services are in or out of network. (A 'network' is a group of providers who contract to provide services for the specific insurance company and plan.) PPO plans may provide more options to receive out-of-network care. Private Fee-for-Service (PFFS) plans: PFFS plans let you receive care from any Medicare-approved provider who will accept the approved fee from your plan. Special Needs Plans (SNPs): SNPs offer additional help for medical costs associated with specific chronic health conditions. Medicare Savings Account (MSA) plans: MSA plans combine a high-deductible health plan with a medical savings account. Each plan offers options to accommodate your healthcare needs. For example, if you have chronic health conditions, SNPs are designed to help alleviate some long-term costs. On the other hand, a PFFS or MSA plan might be beneficial if you travel and need to see out-of-network healthcare professionals. When do you sign up for a Medicare Advantage plan? The Medicare enrollment process can begin as early as 3 months before you or your loved one turns 65 years old. This is the best time to apply, as it will ensure that you receive coverage by your 65th birthday. You can wait to apply for Medicare until the month of your 65th birthday or the 3 months following your birthday. However, coverage can be delayed if you wait, so try to apply early. If you decide not to enroll in a Medicare Advantage plan when you first turn age 65, you have another chance during Medicare's annual open enrollment period. From October 15 through December 7 each year, you can switch from Original Medicare to Medicare Advantage. You can also switch from one Medicare Advantage plan to another or add, remove, or change a Part D plan. The takeaway There are many factors that can influence which Medicare Advantage plan you choose. Consider the CMS star rating, your priorities and healthcare needs, how much you can afford, and what type of insurance you currently have. It's important to enroll in Medicare before you turn age 65 to ensure that you don't go without medical coverage. Don't forget that you have the power to shop around for the best Medicare Advantage plan that fits all your needs. The information on this website may assist you in making personal decisions about insurance, but it is not intended to provide advice regarding the purchase or use of any insurance or insurance products. Healthline Media does not transact the business of insurance in any manner and is not licensed as an insurance company or producer in any U.S. jurisdiction. Healthline Media does not recommend or endorse any third parties that may transact the business of insurance.
